Author:
Villain N.,Planche V.,Levy R.
Subject
Neurology (clinical),Neurology
Reference121 articles.
1. International Conference on Alzheimer's & Parkinson's Diseases 2011 | ALZFORUM n.d. https://www.alzforum.org/print-series/188576.(accessed January 18, 2022).
2. Differential in vitro and in vivo binding profiles of BIIB037 and other anti-abeta clinical antibody candidates;Bussiere;Neurodegener Dis,2013
3. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease;Sevigny;Nature,2016
4. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup;Sperling;Alzheimer Dement J Alzheimer Assoc,2011
5. First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease;Ferrero;Alzheimer Dement Transl Res Clin Interv,2016
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献